Company Accounts and Tax Online 04098979 Board of Directors 1.11.24 31.10.25 31.10.25 false iso4217:GBP xbrli:pure 04098979 2023-11-01 2024-10-31 04098979 2025-10-31 04098979 2024-11-01 2025-10-31 04098979 2024-10-31 04098979 countries:EnglandWales 2024-11-01 2025-10-31 04098979 curr:PoundSterling 2024-11-01 2025-10-31 04098979 uk-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 04098979 uk-bus:Micro-entities 2024-11-01 2025-10-31 04098979 uk-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 04098979 uk-bus:FullAccounts 2024-11-01 2025-10-31 04098979 uk-bus:RegisteredOffice 2024-11-01 2025-10-31 04098979 uk-bus:Director1 2024-11-01 2025-10-31 04098979 uk-bus:Director1 2024-11-01 04098979 uk-bus:Director1 2025-10-31 04098979 core:AfterOneYear 2025-10-31 04098979 core:AfterOneYear 2024-10-31 04098979 core:WithinOneYear 2025-10-31 04098979 core:WithinOneYear 2024-10-31 04098979 core:WithinOneYear 2024-11-01 2025-10-31 04098979 core:AfterOneYear 2025-10-31 04098979 core:AfterOneYear 2024-10-31 04098979 core:AfterOneYear 2024-11-01 2025-10-31 04098979 core:ShareCapital 2025-10-31 04098979 core:ShareCapital 2024-10-31 04098979 core:RevaluationReserve 2025-10-31 04098979 core:RevaluationReserve 2024-10-31 04098979 core:RetainedEarningsAccumulatedLosses 2025-10-31 04098979 core:RetainedEarningsAccumulatedLosses 2024-10-31 04098979 1 2024-11-01 2025-10-31

# MEDICAL GENOMICS LTD

## Company Registration Number:
04098979 (England and Wales)

## Unaudited micro entity accounts for the year ended 31 October 2025

## Period of accounts

## Start date: 01 November 2024

## End date: 31 October 2025

# MEDICAL GENOMICS LTD

## Contents of the Financial Statements

for the Period Ended 31 October 2025

Company Information - 3 |
Report of the Directors - 4 |
Profit and Loss Account - 5 |
Balance sheet - 6 |
Footnotes to the Balance Sheet - 8 |

# MEDICAL GENOMICS LTD

## Company Information

for the Period Ended 31 October 2025

Director: |  | Andrei Semikhodskii
Registered office: |  | 134 Somerset Road Wimbledon London SW19 5HP
Company Registration Number: |  | 04098979 (England and Wales)

# MEDICAL GENOMICS LTD

## Directors' Report Period Ended 31 October 2025

The directors present their report with the financial statements of the company for the period ended 31 October 2025

Principal Activities

Forensic DNA consultancy

Additional information

The business activities of the company were severely affected by the consequences of SARS-CoV2 pandemics and by the war in Ukraine

Directors

The directors shown below have held office during the whole of the period from 01 November 2024 to 31 October 2025
Andrei Semikhodskii

This report was approved by the board of directors on 20 March 2026
And Signed On Behalf Of The Board By:

Name: Andrei Semikhodskii
Status: Director

# MEDICAL GENOMICS LTD

## Profit and Loss Account

for the Period Ended 31 October 2025

| 2025 £ | 2024 £
--- | --- | ---
Turnover | 731 | 1,035
Cost of Materials | ( 2,673 ) | ( 1,479 )
Profit or (Loss) for Period | ( 1,942 ) | ( 444 )

# MEDICAL GENOMICS LTD

## Balance sheet

As at 31 October 2025

| 2025 £ | 2024 £
--- | --- | ---
Current assets: | 13,362 | 13,363
Creditors: amounts falling due within one year: | ( 103,453 ) | ( 101,366 )
Net current assets (liabilities): | ( 90,091 ) | ( 88,003 )
Total assets less current liabilities: | ( 90,091 ) | ( 88,003 )
Creditors: amounts falling due after more than one year: | ( 205,187 ) | ( 194,136 )
Total net assets (liabilities): | ( 295,278 ) | ( 282,139 )
Capital and reserves: | ( 295,278 ) | ( 282,139 )

# MEDICAL GENOMICS LTD

## Balance sheet continued

For the year ending 31 October 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 20 March 2026
And Signed On Behalf Of The Board By:

Name: Andrei Semikhodskii
Status: Director

The notes form part of these financial statements

# MEDICAL GENOMICS LTD

## Footnotes to the Financial Statements

for the Period Ended 31 October 2025

- ## 1. Employee Information

  Average number of employees: 1

# MEDICAL GENOMICS LTD

## Footnotes to the Financial Statements

for the Period Ended 31 October 2025

- ## 2. Off balance sheet disclosure

  No